Mark Pearson
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Metabolism, Diabetes, and Cancer
Papers in
-
- Retinoids in leukemia and cellular processes 6
- Protein Degradation and Inhibitors 4
- DNA Repair Mechanisms 3
-
- Fiscal Policy and Economic Growth 6
- Co-authors
- Pier Giuseppe Pelicci (7 shared papers)Saverio Minucci (3 shared papers)Roberta Carbone (3 shared papers)Ettore Appella (2 shared papers)M Fagioli (2 shared papers)Carla Sebastiani (1 shared paper)Pier Paolo Pandolfi (1 shared paper)Shinichi Saito (1 shared paper)
- Journals
- Cancer Research (7 papers)Proceedings of the National Academy of Sciences (2 papers)The EMBO Journal (2 papers)Cancer Cell (2 papers)Journal of Urban Health (2 papers)
- Partner nations
- United StatesAustriaFrance
In The Last Decade
Mark Pearson
73 papers receiving 3.7k citations
Mark Pearson's Hit Papers
Peers
Comparison fields: 5 of 160
- Hematology 635
- Molecular Biology 2.3k
- Oncology 744
- Endocrinology, Diabetes and Metabolism 408
- Cancer Research 338
Countries citing papers authored by Mark Pearson
This map shows the geographic impact of Mark Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pearson more than expected).
Fields of papers citing papers by Mark Pearson
This network shows the impact of papers produced by Mark Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pearson. The network helps show where Mark Pearson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PML regulates p53 acetylation and premature senescence induced by oncogenic Ras Hit paper breakdown → | 2000 | 692 |
| 2 | 2004 | 471 | |
| 3 | 2004 | 447 | |
| 4 | 2002 | 183 | |
| 5 | 1996 | 173 | |
| 6 | 2002 | 150 | |
| 7 | 2016 | 137 | |
| 8 | 2001 | 103 | |
| 9 | 2004 | 102 | |
| 10 | 2019 | 94 | |
| 11 | 2007 | 86 | |
| 12 | 2017 | 80 | |
| 13 | 2016 | 80 | |
| 14 | Taxing Profits in a Global and Economy: Domestic and International Issues | 1992 | 71 |
| 15 | Taxing profits in a global economy | 1991 | 67 |
| 16 | 2019 | 66 | |
| 17 | 1997 | 55 | |
| 18 | 2009 | 49 | |
| 19 | 1995 | 42 | |
| 20 | 2003 | 41 |
About Mark Pearson
Mark Pearson is a scholar working on Molecular Biology, Economics and Econometrics, Pulmonary and Respiratory Medicine, Oncology and Hematology, having authored 83 papers that have together received 3.8k indexed citations. Recurring topics across this work include Corporate Taxation and Avoidance (7 papers), Fiscal Policy and Economic Growth (6 papers), Retinoids in leukemia and cellular processes (6 papers), Cancer-related Molecular Pathways (6 papers), Social Policy and Reform Studies (4 papers), Protein Degradation and Inhibitors (4 papers), DNA Repair Mechanisms (3 papers) and Gender, Labor, and Family Dynamics (3 papers). The work is most often cited by research in Hematology (635 citations), Molecular Biology (2.3k citations), Oncology (744 citations), Endocrinology, Diabetes and Metabolism (408 citations) and Cancer Research (338 citations). Mark Pearson has collaborated with scholars based in United States, Austria and France. Frequent co-authors include Pier Giuseppe Pelicci, Saverio Minucci, Roberta Carbone, Ettore Appella, M Fagioli, Carla Sebastiani, Pier Paolo Pandolfi, Shinichi Saito, Yuichiro Higashimoto and Mario Cioce. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, The EMBO Journal, Cancer Cell and Journal of Urban Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.